Sign in to continue:

Thursday, March 5th, 2026

Disclosure of Morgan Stanley Bank’s Derivative Dealings in ENN Natural Gas Co., Ltd. Shares – Scheme of Arrangement (March 2026)

Investor Update: Disclosure of Dealings in ENN Natural Gas Co., Ltd. Shares by Morgan Stanley Bank, N.A.

Key Developments in ENN Natural Gas Co., Ltd.: Public Disclosure of Share Dealings

Overview

On 4 March 2026, a public disclosure form was filed regarding significant dealings in the shares of ENN Natural Gas Co., Ltd. (ENN), a leading Chinese natural gas company. The disclosure was made in connection with the company’s privatisation by way of a scheme of arrangement, a process governed by the Hong Kong Code on Takeovers and Mergers.

Key Details of the Disclosure

  • Party Involved: Morgan Stanley Bank, N.A., acting as a Class (5) associate connected with the Offeror and ultimately owned by Morgan Stanley.
  • Nature of Dealings: The dealings involved derivatives linked to A shares of ENN Natural Gas Co., Ltd., conducted for Morgan Stanley Bank, N.A.’s own account.
  • Type of Transactions: The transactions were unsolicited client facilitation trades, both purchases and a significant sale.
  • Settlement Currency: All dealings were conducted in RMB.

Detailed Transaction Breakdown

Date Type Number of Shares Maturity / Closing Out Date Reference Price (RMB) Total Amount (RMB)
3 March 2026 Derivative Purchase 200 28 April 2026 22.6395 4,527.90
3 March 2026 Derivative Purchase 400 29 December 2026 22.9100 9,164.00
3 March 2026 Derivative Purchase 400 29 December 2026 22.9100 9,164.00
3 March 2026 Derivative Purchase 500 27 January 2027 23.0692 11,534.60
3 March 2026 Derivative Sale 18,800 31 August 2027 23.1157 434,575.50

What Investors Should Know

  • Significant Sale Transaction: The most notable transaction is the unsolicited client facilitation sale of 18,800 shares (via derivatives) at a reference price of RMB 23.1157 per share, totaling approximately RMB 434,575.50. This is a substantial notional value and may indicate a change in sentiment or hedging activity by a major international financial institution.
  • Privatisation Process: These transactions are taking place amidst a privatisation scheme for ENN Natural Gas Co., Ltd., which could itself be a price-sensitive event for shareholders. Such schemes often lead to revaluations of the company’s shares and may attract speculative trading.
  • Zero Resultant Balance: For each transaction, the resultant balance is listed as zero, suggesting these were fully closed out and not held as open positions by Morgan Stanley Bank, N.A. going forward. This could indicate a neutral stance or the closing of previous exposures.
  • Potential Market Impact: The involvement of Morgan Stanley Bank, N.A.—a prominent global financial institution—in these trades, especially in the context of unsolicited client facilitation, may signal significant institutional activity in ENN shares. Investors should monitor further disclosures and market developments closely.

Possible Implications for ENN Natural Gas Co., Ltd. Shareholders

The disclosed dealings, particularly the large sale, may be interpreted by the market as a signal of shifting positions by institutional investors in the lead-up to the company’s privatisation. Shareholders should be vigilant for further updates, as such transactions could influence the share price, liquidity, and market perception of ENN Natural Gas Co., Ltd.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors are advised to conduct their own research and consult professional advisors before making investment decisions. The details provided are based on publicly disclosed information and may not reflect the most current or comprehensive view of the company’s situation.


View ENN ENERGY Historical chart here



Xuanzhu Biopharma’s Bireociclib (Xuanyuening) Gains NMPA Approval for First-Line HR+/HER2- Advanced Breast Cancer Treatment in China

Xuanzhu Biopharmaceutical Gains Third Indication Approval for Bireociclib Tablets Xuanzhu Biopharmaceutical Secures Third Indication Approval for Bireociclib Tablets — Major Expansion in Advanced Breast Cancer Market Key Highlights Bireociclib Tablets (Xuanyuening) granted third marketing...

Mingfa Group Progress Update on PRC Subsidiaries Board Restructuring – February 2026 Announcement 12

Mingfa Group (International) Announces Progress Update on PRC Subsidiaries Board Restructuring Mingfa Group (International) Company Limited: Detailed Progress Update on Restructuring of PRC Subsidiaries’ Boards Key Points of the Announcement Continued Progress on Board...

Country Garden Holdings Update: High Court Dismisses Winding-Up Petition (February 2026)

Country Garden Holdings: Winding-Up Petition Dismissed Country Garden Holdings Company Limited: High Court Dismisses Winding-Up Petition Key Highlights Winding-Up Petition Dismissed: The High Court has officially dismissed the winding-up petition against Country Garden Holdings...

   Ad